Whitehawk Therapeutics
WHWK | NASDAQ
$3.01
-$0.05 (-1.63%)
At close: Nov 16, 2026, 4:00 PM ET
$3.08
+$0.07 (+2.33%)
After-hours:
Nov 16, 2026, 7:32 PM ET
-1.63%
(1D)Rating
34.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #672/1021 (Top 66%)
Key Statistics
Market Data
Market Cap $282.54M
1D Range
2.94 3.06
52W Range
1.99 5.10
Valuation (TTM)
PE -2.76
PB 1.73
EV/EBITDA -1.31
Valuation (NTM)
Forward PE N/A
Forward PEG -0.00
Price Target $9.00
Cash Flow
FCF Yield -26.1%
SBC Adj. FCF Yield -28.8%
SBC Impact -10.7%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -95.3% |
-20.9%
Dil EPS 3Y | 5Y 55.3% |
36.6%
FCF 3Y | 5Y -11.4% |
-11.2%
Returns
ROA -48.0%
ROE -55.7%
ROIC -54.8%
Financial Health
Net Cash
$169.45M
Current Ratio 16.47
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody dru...
Sector Healthcare
Industry Biotechnology
Employees 32
IPO Date Aug 1, 2017
Website ir.whitehawktx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove WHWK